JP6366241B2 - Fine particle metal oxide and external preparation for skin containing the fine particle metal oxide - Google Patents
Fine particle metal oxide and external preparation for skin containing the fine particle metal oxide Download PDFInfo
- Publication number
- JP6366241B2 JP6366241B2 JP2013178816A JP2013178816A JP6366241B2 JP 6366241 B2 JP6366241 B2 JP 6366241B2 JP 2013178816 A JP2013178816 A JP 2013178816A JP 2013178816 A JP2013178816 A JP 2013178816A JP 6366241 B2 JP6366241 B2 JP 6366241B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- external preparation
- fine particle
- metal oxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000004706 metal oxides Chemical class 0.000 title claims description 41
- 229910044991 metal oxide Inorganic materials 0.000 title claims description 37
- 238000002360 preparation method Methods 0.000 title claims description 35
- 239000010419 fine particle Substances 0.000 title description 50
- 229920001296 polysiloxane Polymers 0.000 claims description 75
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 44
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 43
- 239000002537 cosmetic Substances 0.000 claims description 34
- 125000004432 carbon atom Chemical group C* 0.000 claims description 31
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 30
- 125000000217 alkyl group Chemical group 0.000 claims description 27
- 239000011787 zinc oxide Substances 0.000 claims description 22
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 238000006116 polymerization reaction Methods 0.000 claims description 11
- 125000005843 halogen group Chemical group 0.000 claims description 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 7
- 125000003277 amino group Chemical group 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 6
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 3
- -1 silica or alumina Chemical class 0.000 description 31
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 26
- 239000004408 titanium dioxide Substances 0.000 description 20
- 239000000203 mixture Substances 0.000 description 19
- 239000006096 absorbing agent Substances 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 14
- 230000000475 sunscreen effect Effects 0.000 description 14
- 239000000516 sunscreening agent Substances 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- 229960005150 glycerol Drugs 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 239000010936 titanium Substances 0.000 description 5
- 229910052719 titanium Inorganic materials 0.000 description 5
- 229910001111 Fine metal Inorganic materials 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000004381 surface treatment Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- KLPCZNSIPDGAJJ-UHFFFAOYSA-N 2-methoxy-3,3-dimethyl-1-phenylbutan-1-one Chemical compound COC(C(C)(C)C)C(=O)C1=CC=CC=C1 KLPCZNSIPDGAJJ-UHFFFAOYSA-N 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 2
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 229960003921 octisalate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229940112824 paste Drugs 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical group [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229940052228 zinc oxide paste Drugs 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- LTSWUFKUZPPYEG-UHFFFAOYSA-N 1-decoxydecane Chemical compound CCCCCCCCCCOCCCCCCCCCC LTSWUFKUZPPYEG-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229920006310 Asahi-Kasei Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、分散媒中での分散性が改善された微粒子金属酸化物に関し、また、該微粒子金属酸化物を含有する皮膚外用剤に関する。 The present invention relates to a fine particle metal oxide having improved dispersibility in a dispersion medium, and also relates to a skin external preparation containing the fine particle metal oxide.
化粧料、特にメークアップ化粧料には、高い紫外線防御効果が求められる。化粧料に高い紫外線防御効果を付与するために、化粧料中に320〜400nm波長(A領域)の紫外線を吸収するいわゆるUV−A吸収剤、及び290〜320nm波長(B領域)の紫外線を吸収するいわゆるUV−B吸収剤を配合することが行われている。これらの紫外線吸収剤は高粘性の油剤であり、高い紫外線防御効果を得るために紫外線吸収剤を高濃度で配合させると、化粧料の使用感が損なわれるという問題が生じる。 Cosmetics, particularly makeup cosmetics, are required to have a high UV protection effect. In order to impart a high UV protection effect to cosmetics, so-called UV-A absorbers that absorb 320 to 400 nm wavelength (A region) UV rays and 290 to 320 nm wavelength (B region) UV rays are absorbed in cosmetics. So-called UV-B absorbers are blended. These ultraviolet absorbents are highly viscous oils, and when a high concentration of the ultraviolet absorbent is blended in order to obtain a high ultraviolet protective effect, there is a problem that the feeling of use of the cosmetic is impaired.
紫外線吸収剤を高濃度で配合させた化粧料の使用感を改善するための試みとして、微粒子金属酸化物を配合させることが検討されている。微粒子金属酸化物を含有する化粧料において、高い紫外線吸収効果を発揮するためには化粧料中で微粒子金属酸化物を均一に分散させる必要があり、微粒子金属酸化物に表面処理を行って分散性を向上させる技術が提案されている(例えば特許文献1、2参照)。 As an attempt to improve the feeling of use of a cosmetic containing a high concentration of an ultraviolet absorber, it has been studied to add a particulate metal oxide. In cosmetics containing fine metal oxides, it is necessary to uniformly disperse the fine metal oxides in the cosmetics in order to exert a high UV absorption effect. Have been proposed (see, for example, Patent Documents 1 and 2).
本発明は、紫外線吸収剤を配合させた皮膚外用剤において、十分な紫外線防御効果を有し、かつ良好な使用感を有する皮膚外用剤を提供することを課題とする。 This invention makes it a subject to provide the skin external preparation which has a sufficient ultraviolet-ray protective effect and has a favorable usability in the skin external preparation which mix | blended the ultraviolet absorber.
本発明者らは、上記課題を解決すべく検討したところ、従来提案されている技術では、微粒子金属酸化物の分散性が未だ十分ではないために、紫外線吸収効果が十分ではなく、かつ、皮膚外用剤を使用した際の使用感も十分ではないことに想到した。そこで、微粒子金属酸化物の分散性を向上させるべく、微粒子金属酸化物の表面処理方法を検討したところ、(a)特定の構造を有する反応性オルガノポリシロキサン、及び(b)少なくとも1つのフェニル基を有するオルガノポリシロキサンで微粒子金属酸化物の表面を処理することで、上記課題を解決できることを見出し、本発明を完成させた。 The inventors of the present invention have studied to solve the above-described problems. As a result, the conventionally proposed technique does not have sufficient dispersibility of the fine particle metal oxide, so that the ultraviolet absorption effect is not sufficient, and the skin It was thought that the feeling of use when using an external preparation was not sufficient. Then, in order to improve the dispersibility of the fine particle metal oxide, the surface treatment method of the fine particle metal oxide was examined. As a result, (a) a reactive organopolysiloxane having a specific structure, and (b) at least one phenyl group. The present inventors have found that the above-mentioned problems can be solved by treating the surface of the fine-particle metal oxide with an organopolysiloxane having the present invention.
本発明の第一の実施態様は、以下のとおりである。
(1)(a)重合度が25以上100以下、重量平均分子量Mwと数平均分子量Mnとの比Mw/Mnの値が1以上1.3以下であって、少なくとも一方の分子鎖末端にアルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択される少なくとも1種を有する直鎖状の反応性オルガノポリシロキサン、及び(b)少なくとも1つのフェニル基を有するオルガノポリシロキサン、で被覆された、微粒子金属酸化物。
(2)前記(b)少なくとも1つのフェニル基を有するオルガノポリシロキサンが、下記一般式(3)で表される、(1)に記載の微粒子金属酸化物。
(3)前記式(3)において、R3は独立して、炭素数1〜3のアルキル基、及び炭素数1〜3のアルコキシ基から選択され、R4は独立して炭素数1〜3のアルキル基、下記一般式(4)で表される基及びフェニル基から選択されるとともに、フェニル基を有するユニットを少なくとも1つ有する、(2)に記載の微粒子金属酸化物。
(4)前記式(3)において、R3は独立して、炭素数1〜3のアルキル基から選択され、R4は独立して炭素数1〜3のアルキル基、下記一般式(4)で表される基及びフェニル基から選択されるとともに、フェニル基を有するユニットを少なくとも1つ有する、(2)または(3)に記載の微粒子金属酸化物。
(5)前記微粒子金属酸化物が微粒子酸化チタン、及び微粒子酸化亜鉛から選択される少なくとも1種を含む、(1)〜(4)のいずれかに記載の微粒子金属酸化物。
The first embodiment of the present invention is as follows.
(1) (a) The degree of polymerization is 25 or more and 100 or less, the ratio Mw / Mn between the weight average molecular weight Mw and the number average molecular weight Mn is 1 or more and 1.3 or less, and at least one molecular chain terminal is alkoxylated A linear reactive organopolysiloxane having at least one selected from the group consisting of a group, a hydroxyl group, a halogen atom, an amino group and an imino group, and (b) an organopolysiloxane having at least one phenyl group. Coated, particulate metal oxide.
(2) The fine particle metal oxide according to (1), wherein (b) the organopolysiloxane having at least one phenyl group is represented by the following general formula (3).
(3) In the formula (3), R 3 is independently selected from an alkyl group having 1 to 3 carbon atoms and an alkoxy group having 1 to 3 carbon atoms, and R 4 is independently selected from 1 to 3 carbon atoms. The fine-particle metal oxide according to (2), which is selected from an alkyl group of the above, a group represented by the following general formula (4), and a phenyl group, and having at least one unit having a phenyl group.
(4) In the formula (3), R 3 is independently selected from an alkyl group having 1 to 3 carbon atoms, R 4 is independently an alkyl group having 1 to 3 carbon atoms, and the following general formula (4) The fine particle metal oxide according to (2) or (3), which is selected from the group represented by formula (I) and a phenyl group, and has at least one unit having a phenyl group.
(5) The particulate metal oxide according to any one of (1) to (4), wherein the particulate metal oxide contains at least one selected from particulate titanium oxide and particulate zinc oxide.
また、本発明の第二の実施態様は、以下のとおりである。
(6)(1)〜(5)のいずれかに記載の微粒子金属酸化物、及び紫外線吸収剤を含有する皮膚外用剤。
(7)A領域の紫外線を吸収する紫外線吸収剤、及びB領域の紫外線を吸収する紫外線吸収剤、を含有する(6)に記載の皮膚外用剤。
(8)化粧料である、(6)または(7)に記載の皮膚外用剤。
The second embodiment of the present invention is as follows.
(6) A skin external preparation containing the particulate metal oxide according to any one of (1) to (5) and an ultraviolet absorber.
(7) The skin external preparation described in (6), which contains an ultraviolet absorber that absorbs ultraviolet rays in the A region and an ultraviolet absorber that absorbs ultraviolet rays in the B region.
(8) The external preparation for skin according to (6) or (7), which is a cosmetic.
本発明によれば、高い紫外線防御効果を有し、かつ使用感を損なわない皮膚外用剤を提供できる。また、このような皮膚外用剤に含有させる微粒子金属酸化物を提供できる。 According to the present invention, high it has ultraviolet ray defense effect, and can provide a skin external preparation which does not impair the feeling. Moreover, the fine particle metal oxide contained in such a skin external preparation can be provided.
本発明の第一の実施態様は、2種類のオルガノポリシロキサンで表面処理された微粒子金属酸化物である。
微粒子金属酸化物は、皮膚外用剤に配合し得る金属酸化物であればその種類は特段限定されない。金属酸化物の例示としては、二酸化チタン、酸化亜鉛、酸化ジルコニウム、酸化セリウム等があげられる。これらの金属酸化物は、その表面がシリカ、アルミナ等の無機化合物、または脂肪酸金属石鹸、シリコーン等の有機化合物により被覆されてもよい。
The first embodiment of the present invention is a particulate metal oxide surface-treated with two types of organopolysiloxanes.
The type of the particulate metal oxide is not particularly limited as long as it is a metal oxide that can be blended into the external preparation for skin. Examples of metal oxides include titanium dioxide, zinc oxide, zirconium oxide, cerium oxide and the like. The surface of these metal oxides may be coated with an inorganic compound such as silica or alumina, or an organic compound such as fatty acid metal soap or silicone.
微粒子金属酸化物は、当該技術分野において微粒子と称される粒子径を有するものであり、例えば、電子顕微鏡観察による一次粒子径が通常5nm以上、好ましくは10nm以上、また通常100nm以下、好ましくは80nm以下のものである。
本実施態様で用いられる微粒子金属酸化物は、紫外線吸収効果に優れることから、微粒子二酸化チタン、及び微粒子酸化亜鉛からなる群から選択される少なくとも1種を含むことが好ましい。
The fine particle metal oxide has a particle size referred to as a fine particle in the technical field. For example, the primary particle size by electron microscope observation is usually 5 nm or more, preferably 10 nm or more, and usually 100 nm or less, preferably 80 nm. It is as follows.
The fine particle metal oxide used in this embodiment preferably has at least one selected from the group consisting of fine particle titanium dioxide and fine particle zinc oxide because of its excellent ultraviolet absorption effect.
本実施態様で用いる微粒子金属酸化物は、該当する金属の塩を気相中で熱分解する等の常法により調製することが可能であるが、多くの市販品も存在するので、市販品をそのまま用いることもできる。このような市販品としては、具体的には、微粒子二酸化チタンとして、「MTY−110M3S」(テイカ(株)製)、「MTY−02」(テイカ(株)製)、「MT−100TV」(テイカ(株)製)、「MT−500HSA」(テイカ(株)製)、「MT−100T」(テイカ(株)製)、「MT−01」(テイカ(株)製)、「MT−10EX」(テイカ(株)製)、「MT−05」(テイカ(株)製)、「MT−100Z」(テイカ(株)製)、「MT−150EX」(テイカ(株)製)、「MT−100AQ」(テイカ(株)製)、「MT−100WP」(テイカ(株)製)、「MT−100SA」(テイカ(株)製)、「MT−500B」(テイカ(株)製)、「MT−500SA」(テイカ(株)製、「MT−600B」(テイカ(株)製)、「MT−500SAS」(テイカ(株)製)、)「タイペークCR−50」(石原産業(株)製)、「タイペークTTO−M−1」(石原産業(株)製)「タイペークTTO−V4」(石原産業(株)製)、「ST−455」(チタン工業(株)製)、「STT−65C−S」(チタン工業(株)製)、「STT−30EHS」(チタン工業(株)製)、「バイエルチタンR−KB−1」(バイエル社製)等が挙げられる。 The fine particle metal oxide used in the present embodiment can be prepared by a conventional method such as thermal decomposition of the corresponding metal salt in the gas phase, but there are many commercially available products. It can also be used as it is. Specific examples of such commercially available products include “MTY-110M3S” (manufactured by Teica), “MTY-02” (manufactured by Teica), “MT-100TV” ( (Taika Corporation), “MT-500HSA” (Taika Corporation), “MT-100T” (Taika Corporation), “MT-01” (Taika Corporation), “MT-10EX” ”(Manufactured by Teika),“ MT-05 ”(manufactured by Teika),“ MT-100Z ”(manufactured by Teica),“ MT-150EX ”(manufactured by Teica),“ MT -100AQ "(manufactured by Teika)," MT-100WP "(manufactured by Teika)," MT-100SA "(manufactured by Teica)," MT-500B "(manufactured by Teica), “MT-500SA” (manufactured by Teika Co., Ltd., “MT-600B”) ) "MT-500SAS" (manufactured by Teika Co., Ltd.), "Taipeke CR-50" (manufactured by Ishihara Sangyo Co., Ltd.), "Taipeke TTO-M-1" (Ishihara Sangyo Co., Ltd.) "Taipaque TTO-V4" (Ishihara Sangyo Co., Ltd.), "ST-455" (Titanium Industry Co., Ltd.), "STT-65C-S" (Titanium Industry Co., Ltd.), "STT- 30EHS "(manufactured by Titanium Industry Co., Ltd.)," Bayer Titanium R-KB-1 "(manufactured by Bayer) and the like.
また、微粒子酸化亜鉛として、「MZ−300」(テイカ(株)製)、「MZY−303S」(テイカ(株)製)、「MZ−306X」(テイカ(株)製)、「MZ−500」(テイカ(株)製)、「MZY−505S」(テイカ(株)製)、「MZ−506X」(テイカ(株)製)、「MZ−510HPSX」(テイカ(株)製)、「WSX−MZ−700」(テイカ(株)製)、「SAMT−UFZO−450」(三好化成(株)製)、「SAMT−UFZO−500」(三好化成(株)製)、「FZO−50」(石原産業(株)製)、「マックスライトZS−032」(昭和電工(株)製)、「マックスライトZS−032D」(昭和電工(株)製)等が挙げられる。 Further, as fine particle zinc oxide, “MZ-300” (manufactured by Teika), “MZY-303S” (manufactured by Teika), “MZ-306X” (manufactured by Teica), “MZ-500”. "(Manufactured by Teica)," MZY-505S "(manufactured by Teika)," MZ-506X "(manufactured by Teica)," MZ-510HPSX "(manufactured by Teica)," WSX -MZ-700 "(manufactured by Teika Co., Ltd.)," SAMT-UFZO-450 "(manufactured by Miyoshi Kasei Co., Ltd.)," SAMT-UFZO-500 "(manufactured by Miyoshi Kasei Co., Ltd.)," FZO-50 " (Manufactured by Ishihara Sangyo Co., Ltd.), “Maxlite ZS-032” (manufactured by Showa Denko KK), “Maxlite ZS-032D” (manufactured by Showa Denko KK) and the like.
本実施態様に係る微粒子金属酸化物は、(a)特定の構造を有する反応性オルガノポリシロキサン、及び(b)少なくとも1つのフェニル基を有するオルガノポリシロキサンで被覆される。
本発明者らは、微粒子金属酸化物を上記(a)、(b)2種類のオルガノポリシロキサンで被覆することで、紫外線吸収剤を含む分散媒中における、微粒子金属酸化物の分散性が改善され、皮膚外用剤とした際に十分な紫外線吸収効果を奏し、かつ、使用感も良いことに想到した。
The particulate metal oxide according to this embodiment is coated with (a) a reactive organopolysiloxane having a specific structure, and (b) an organopolysiloxane having at least one phenyl group.
The present inventors improved the dispersibility of the particulate metal oxide in the dispersion medium containing the ultraviolet absorber by coating the particulate metal oxide with the above-mentioned two types of organopolysiloxanes (a) and (b). It was conceived that when it was used as an external preparation for skin, it exhibited a sufficient ultraviolet absorption effect and had a good usability.
(a)オルガノポリシロキサンは、直鎖状の反応性オルガノポリシロキサンであり、重
合度が25以上100以下、重量平均分子量Mwと数平均分子量Mnとの比Mw/Mnの値が1以上1.3以下であって、少なくとも一方の分子鎖末端にアルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択される少なくとも1種を有する。
アルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択される反応基は少なくとも一方の分子鎖末端に存在すればよく、両方の分子鎖末端に存在してもよいが、微粒子金属酸化物との反応性等の観点からは、一方のみの分子鎖末端にこれらの反応基のうち少なくとも1種が存在すればよい。
アルコキシ基としては、炭素数が1以上5以下のものが好ましく、炭素数が1以上3以下のもの、すなわちメトキシ基、エトキシ基、プロポキシ基がより好ましい。
ハロゲン原子としては、塩素、臭素、ヨウ素等が好ましい。
(A) The organopolysiloxane is a linear reactive organopolysiloxane having a degree of polymerization of 25 to 100 and a ratio Mw / Mn of the weight average molecular weight Mw to the number average molecular weight Mn of 1 to 1. 3 or less, and at least one molecular chain terminal has at least one selected from the group consisting of an alkoxy group, a hydroxyl group, a halogen atom, an amino group, and an imino group.
The reactive group selected from the group consisting of an alkoxy group, a hydroxyl group, a halogen atom, an amino group and an imino group may be present at at least one molecular chain end, and may be present at both molecular chain ends. From the viewpoint of reactivity with oxides, etc., at least one of these reactive groups may be present at only one molecular chain end.
As an alkoxy group, a C1-C5 thing is preferable and a C1-C3 thing, ie, a methoxy group, an ethoxy group, and a propoxy group are more preferable.
As the halogen atom, chlorine, bromine, iodine and the like are preferable.
本実施態様に用いられる(a)反応性オルガノポリシロキサンは、重合度が25以上100以下である。好ましくは30以上である。また、60以下であることが好ましく、50以下であることがより好ましい。
重合度をこの範囲とすることで、化粧料に配合した際の使用性、及び微粒子金属酸化物との反応性が良好となる。
The degree of polymerization of the (a) reactive organopolysiloxane used in this embodiment is 25 or more and 100 or less. Preferably it is 30 or more. Moreover, it is preferable that it is 60 or less, and it is more preferable that it is 50 or less.
By setting the degree of polymerization within this range, the usability when blended in a cosmetic and the reactivity with the fine particle metal oxide are improved.
本実施態様に用いられる(a)反応性オルガノポリシロキサンは、重量平均分子量Mwと数平均分子量Mnとの比Mw/Mnの値(以下、分子量分散度ともいう。)が1以上1.3以下である。Mw/Mnの値がこの範囲内にあることで、分子量分布がシャープとなり、化粧料に配合した際に良好な使用感が得やすくなる。重量平均分子量と数平均分子量は、例えばGPC(ゲルパーミエーションクロマトグラフィー)により求めることができる。 The (a) reactive organopolysiloxane used in this embodiment has a ratio Mw / Mn (hereinafter also referred to as molecular weight dispersity) of the weight average molecular weight Mw and the number average molecular weight Mn of 1 or more and 1.3 or less. It is. When the value of Mw / Mn is within this range, the molecular weight distribution becomes sharp, and it is easy to obtain a good feeling when used in cosmetics. The weight average molecular weight and the number average molecular weight can be determined by GPC (gel permeation chromatography), for example.
本実施態様に用いられる(a)反応性オルガノポリシロキサンの具体例としては、以下の一般式(1)および(2)で表されるポリオルガノシロキサンがあげられる。
上記式(1)および(2)中、R1は独立して、炭素数1〜3のアルキル基から選択される。炭素数1〜3のアルキル基とは、メチル基、エチル基、プロピル基である。
上記式(1)中、R2は独立して、アルキル基、アルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択され、R2のうち少なくとも1つは、アルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択される反応基である。アルコキシ基としては、炭素数1〜3のアルコキシ基であることが好ましく、メトキシ基、エトキシ基、プロポキシ基が好ましい。ハロゲン原子としては、塩素、臭素、ヨウ素が好ましい。
Rは独立して、単結合、及び二価の炭化水素基から選択され、二価の炭化水素基である場合には、その水素原子が水酸基、メトキシ基、エトキシ基、メチル基、又はエチル基で置換されていてもよい。二価の炭化水素基としては、メチレン基、エチレン基、プロペン基等が例示される。
mは通常25以上、好ましくは30以上であり、また、通常100以下、好ましくは60以下であり、より好ましくは50以下である。
In the above formulas (1) and (2), R 1 is independently selected from alkyl groups having 1 to 3 carbon atoms. A C1-C3 alkyl group is a methyl group, an ethyl group, and a propyl group.
In the above formula (1), R 2 is independently selected from the group consisting of an alkyl group, an alkoxy group, a hydroxyl group, a halogen atom, an amino group, and an imino group, and at least one of R 2 is an alkoxy group, a hydroxyl group , A reactive group selected from the group consisting of a halogen atom, an amino group and an imino group. As an alkoxy group, it is preferable that it is a C1-C3 alkoxy group, and a methoxy group, an ethoxy group, and a propoxy group are preferable. As the halogen atom, chlorine, bromine and iodine are preferable.
R is independently selected from a single bond and a divalent hydrocarbon group, and when it is a divalent hydrocarbon group, the hydrogen atom is a hydroxyl group, a methoxy group, an ethoxy group, a methyl group, or an ethyl group May be substituted. Examples of the divalent hydrocarbon group include a methylene group, an ethylene group, and a propene group.
m is usually 25 or more, preferably 30 or more, and is usually 100 or less, preferably 60 or less, more preferably 50 or less.
上記(a)反応性オルガノポリシロキサンの更なる具体例としては、例えば、ジメチルポリシロキシシラザン、α−モノヒドロキシシロキサン、α,ω−ジヒドロキシポリジメチルシロキサン、α−モノアルコキシポリジメチルシロキサン、α−ジアルコキシポリジメチルシロキサン、α−トリアルコキシポリジメチルシロキサン、α,ω−ジアルコキシジメチルポリシロキサン、α,ω−ヘキサアルコキシポリジメチルポリシロキサン、ジメチルポリシロキシクロライド、ジメチルポリシロキシブロミド、及びジメチルポリシロキシイオジド等が挙げられる。
中でも、α−モノアルコキシポリジメチルシロキサン、α−ジアルコキシポリジメチルシロキサン及びα−トリアルコキシポリジメチルシロキサン(例として、α−トリエトキシポリジメチルシロキサン等)が、反応性が非常に良好であり、特に滑らかな感触を付与するので好ましい。
As further specific examples of the above-mentioned (a) reactive organopolysiloxane, for example, dimethylpolysiloxysilazane, α-monohydroxysiloxane, α, ω-dihydroxypolydimethylsiloxane, α-monoalkoxypolydimethylsiloxane, α-di Alkoxypolydimethylsiloxane, α-trialkoxypolydimethylsiloxane, α, ω-dialkoxydimethylpolysiloxane, α, ω-hexaalkoxypolydimethylpolysiloxane, dimethylpolysiloxane chloride, dimethylpolysiloxybromide, and dimethylpolysiloxy iodide Etc.
Among them, α-monoalkoxypolydimethylsiloxane, α-dialkoxypolydimethylsiloxane and α-trialkoxypolydimethylsiloxane (for example, α-triethoxypolydimethylsiloxane) have very good reactivity. This is preferable because it provides a smooth feel.
上記(b)オルガノポリシロキサンは、フェニル基を有するオルガノポリシロキサンである。(b)オルガノポリシロキサンはフェニル基を有する限り特段その種類は限定されず、例えば、下記一般式(3)で表されるオルガノポリシロキサンを例示できる。 The (b) organopolysiloxane is an organopolysiloxane having a phenyl group. (B) As long as the organopolysiloxane has a phenyl group, the type thereof is not particularly limited, and examples thereof include organopolysiloxanes represented by the following general formula (3).
上記式(3)中、R3は独立して、水素、炭素数1〜3のアルキル基、及び炭素数1〜3のアルコキシ基から選択される。好ましくは、R3は独立して、炭素数1〜3のアルキル基、及び炭素数1〜3のアルコキシ基から選択され、より好ましくは、R3は独立して、炭素数1〜3のアルキル基から選択される。
R4は独立して水素、炭素数1〜3のアルキル基、下記一般式(4)で表される基及びフェニル基から選択されるとともに、フェニル基を有するユニットを少なくとも1つ有する。好ましくは、R4は独立して炭素数1〜3のアルキル基、及びフェニル基から選択されるとともに、フェニル基を有するユニットを少なくとも1つ有する。
nは整数であり、通常3以上、好ましくは5以上、また通常600以下、好ましくは 400以下である。
R 4 is independently selected from hydrogen, an alkyl group having 1 to 3 carbon atoms, a group represented by the following general formula (4), and a phenyl group, and has at least one unit having a phenyl group. Preferably, R 4 is independently selected from an alkyl group having 1 to 3 carbon atoms and a phenyl group, and has at least one unit having a phenyl group.
n is an integer and is usually 3 or more, preferably 5 or more, and usually 600 or less, preferably 400 or less.
上記(b)オルガノポリシロキサンに含まれる好ましい具体例としては、モノフェニルジメチコン、ジフェニルジメチコン、ジフェニルシロキシフェニルトリメチコン、トリメチルシロキシフェニルジメチコンなどがあげられる。これらは定法に従い調製することもできるが、市販品を用いてもよい。
市販品としては、「シリコーンKF54」(信越化学株式会社製)、「シリコーンKF56」(信越化学株式会社製)、「BELSEL PDM 1000」(旭化成ワッカーシリコーン株式会社製)等が例示される。
上記(b)オルガノポリシロキサンの数平均分子量は特段限定されないが、通常500以上、好ましくは800以上、また通常100000以下、好ましくは80000以下である。
Preferable specific examples contained in the (b) organopolysiloxane include monophenyl dimethicone, diphenyl dimethicone, diphenylsiloxyphenyl trimethicone, trimethylsiloxyphenyl dimethicone and the like. These can be prepared according to conventional methods, but commercially available products may also be used.
Examples of commercially available products include “silicone KF54” (manufactured by Shin-Etsu Chemical Co., Ltd.), “silicone KF56” (manufactured by Shin-Etsu Chemical Co., Ltd.), “BELSEL PDM 1000” (manufactured by Asahi Kasei Wacker Silicone Co., Ltd.), and the like.
The number average molecular weight of the (b) organopolysiloxane is not particularly limited, but is usually 500 or more, preferably 800 or more, and usually 100,000 or less, preferably 80000 or less.
上記(a)及び(b)のオルガノポリシロキサンによる、微粒子金属酸化物の表面処理は、定法に従い処理されればよく、例えば必要により溶媒を用いて、ヘンシェルミキサー等の混合機により微粒子金属酸化物とオルガノポリシロキサンを混合し、該混合物を加熱する等の方法があげられる。また、上記(a)及び(b)のオルガノポリシロキサンによる処理の順序についても特段限定されないが、(a)のオルガノポリシロキサンで表面処理を行った後に、(b)のオルガノポリシロキサンで処理することで、本発明の効果がより顕著なものとなり、好ましい。 The surface treatment of the fine metal oxide with the organopolysiloxanes (a) and (b) may be performed according to a conventional method. For example, if necessary, the fine metal oxide is mixed with a mixer such as a Henschel mixer using a solvent. And organopolysiloxane are mixed and the mixture is heated. Further, the order of the treatment with the organopolysiloxanes (a) and (b) is not particularly limited, but after the surface treatment with the organopolysiloxane (a), the treatment with the organopolysiloxane (b) is performed. Thus, the effect of the present invention becomes more remarkable and preferable.
本実施態様に係る微粒子金属酸化物において、上記(a)及び(b)のオルガノポリシロキサンの被覆量は、表面処理後の微粒子金属酸化物に対し、それぞれ通常0.5質量%以上、好ましくは1質量%以上であり、また、通常25質量%以下、好ましくは20質量
%以下である。オルガノポリシロキサンによる被覆量をこの範囲とすることで、本実施態様に係る微粒子金属酸化物の分散性がより良好となり、皮膚外用剤に配合した際に十分な紫外線吸収効果を発揮し、使用感も良好となる。
In the particulate metal oxide according to this embodiment, the coating amount of the organopolysiloxanes (a) and (b) above is usually 0.5% by mass or more, preferably with respect to the particulate metal oxide after the surface treatment. It is 1 mass% or more, and is usually 25 mass% or less, preferably 20 mass% or less. By making the coating amount with the organopolysiloxane within this range, the dispersibility of the fine particle metal oxide according to the present embodiment becomes better, and when it is blended into a skin external preparation, it exhibits a sufficient ultraviolet absorption effect and feels to be used. Will also be good.
また、(a)及び(b)のオルガノポリシロキサンの被覆量の比は特段限定されず、通常質量比で(a):(b)=95:5〜5:95であり、好ましくは80:20〜20;80、より好ましくは70:30〜30:70である。 Moreover, the ratio of the coating amount of the organopolysiloxane (a) and (b) is not particularly limited, and is usually (a) :( b) = 95: 5 to 5:95, preferably 80: 20-20; 80, more preferably 70: 30-30: 70.
本発明の第二の実施態様は、上記第一の実施態様に係る微粒子金属酸化物、及び紫外線吸収剤を含有する皮膚外用剤である。
本実施態様に係る皮膚外用剤において、上記第一の実施態様に係る微粒子金属酸化物の配合量は特段限定されず、化粧料の種類により適宜設定可能であるが、皮膚外用剤全量に対し、通常1質量%以上、好ましくは2質量%以上であり、また、通常70質量%以下、好ましくは50質量%以下、より好ましくは30質量%以下である。
紫外線吸収剤としては、皮膚外用剤に配合し得る紫外線吸収剤であれば特段限定されないが、幅広い波長の紫外線を吸収するために、320〜400nm波長(A領域)の紫外線を吸収するUV−A吸収剤、及び290〜320nm波長(B領域)の紫外線を吸収するUV−B吸収剤を含むことが好ましい。
紫外線吸収剤の配合量は特段限定されず、皮膚外用剤全量に対し、通常0.01質量%以上、好ましくは0.1質量%以上であり、また、通常15質量%以下、好ましくは10質量%以下である。
The second embodiment of the present invention is a skin external preparation containing the particulate metal oxide according to the first embodiment and an ultraviolet absorber.
In the external preparation for skin according to this embodiment, the blending amount of the fine particle metal oxide according to the first embodiment is not particularly limited and can be appropriately set according to the type of cosmetic, It is usually 1% by mass or more, preferably 2% by mass or more, and usually 70% by mass or less, preferably 50% by mass or less, more preferably 30% by mass or less.
The ultraviolet absorber is not particularly limited as long as it is an ultraviolet absorber that can be blended into a skin external preparation, but UV-A that absorbs ultraviolet rays having a wavelength of 320 to 400 nm (A region) in order to absorb ultraviolet rays having a wide range of wavelengths. It is preferable to include an absorber and a UV-B absorber that absorbs ultraviolet rays having a wavelength of 290 to 320 nm (B region).
The blending amount of the ultraviolet absorber is not particularly limited, and is usually 0.01% by mass or more, preferably 0.1% by mass or more, and usually 15% by mass or less, preferably 10% by mass with respect to the total amount of the external preparation for skin. % Or less.
UV−A吸収剤としては、2−ヒドロキシ−4−メトキシベンゾフェノン、2−(2´−ヒドロキシ−5´−メチルフェニル)ベンゾトリアゾール、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸2−エチルヘキシル、ビス(レスルシニル)トリアジン、メチレンビスベンゾトリアゾリルテトラメチルブチルフェノール、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、t−ブチルメトキシベンゾイルメタン等の化合物が例示される。この内でも、紫外線吸収能に優れることから、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、及びt−ブチルメトキシベンゾイルメタンが特に好ましい。これらの化合物には市販品が存在するので、市販品をそのまま用いることができる。具体的な市販品としては「ユビナールAプラス グラニュラー」(ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル BASF社製)、「パルソール1789」(t−ブチルメトキシベンゾイルメタン DSM社製)が例示できる。 Examples of UV-A absorbers include 2-hydroxy-4-methoxybenzophenone, 2- (2′-hydroxy-5′-methylphenyl) benzotriazole, dimethoxybenzylidenedioxoimidazolidinepropionate 2-ethylhexyl, and bis (reslucinyl). Examples include triazine, methylenebisbenzotriazolyltetramethylbutylphenol, hexyl diethylaminohydroxybenzoyl benzoate, t-butylmethoxybenzoylmethane, and the like. Among these, diethylaminohydroxybenzoyl hexyl benzoate and t-butylmethoxybenzoylmethane are particularly preferable because of their excellent ultraviolet absorbing ability. Since these compounds have commercial products, commercial products can be used as they are. Specific commercial products include “Ubinal A Plus Granular” (diethylaminohydroxybenzoyl hexyl benzoate manufactured by BASF) and “Pulsol 1789” (manufactured by t-butylmethoxybenzoylmethane DSM).
UV−A吸収剤の含有量は、皮膚外用剤全量に対して通常0.01質量%以上、好ましくは0.1質量%以上であり、また、通常5質量%以下、好ましくは3質量%以下である。 The content of the UV-A absorber is usually 0.01% by mass or more, preferably 0.1% by mass or more, and usually 5% by mass or less, preferably 3% by mass or less, based on the total amount of the external preparation for skin. It is.
UV−B吸収剤としては、具体的には、パラメトキシ桂皮酸2−エチルヘキシル、2−シアノ−3,3−ジフェニルアクリル酸2−エチルヘキシル、ジメチコジエチルベンザルマロネート、2,4,6−トリアニリノ−p−(カルボ−2´−エチルヘキシル−1´−オキシ)−1,3,5−トリアジン、2−ヒドロキシ−4−メトキシベンゾフェノン、サリチル酸ホモメンチル、サリチル酸オクチル等の化合物があげられる。これらの化合物には市販品が存在するので、市販品をそのまま用いることができる。具体的な市販品としては、「ユビナールMC80」(パラメトキシ桂皮酸2−エチルヘキシル BASF社製)、「ユビナールT150」(2,4,6−トリアニリノ−p−(カルボ−2´−エチルヘキシル−1´−オキシ)−1,3,5−トリアジン BASF社製)、「ユビナールM40」(2−ヒドロキシ−4−メトキシベンゾフェノン BASF社製)、「パルソールSLX」(ジメチコジエチルベンザルマロネート DSM社製)、「パルソール340」(2−シアノ−3,3−ジフェニルアクリル酸2−エチルヘキシル DSM社製)、「パル
ソールHMS」(サリチル酸ホモメンチル DSM社製)、「パルソールEMS」(サリチル酸オクチル DSM社製)が例示できる。
Specific examples of the UV-B absorber include 2-methoxyhexyl paramethoxycinnamate, 2-ethylhexyl 2-cyano-3,3-diphenylacrylate, dimethicodiethylbenzalmalonate, 2,4,6-trianilino Examples include -p- (carbo-2'-ethylhexyl-1'-oxy) -1,3,5-triazine, 2-hydroxy-4-methoxybenzophenone, homomenthyl salicylate, octyl salicylate and the like. Since these compounds have commercial products, commercial products can be used as they are. Specific commercial products include “Ubinal MC80” (2-ethylhexyl paramethoxycinnamate, manufactured by BASF), “Ubinal T150” (2,4,6-trianilino-p- (carbo-2′-ethylhexyl-1′-). Oxy) -1,3,5-triazine (made by BASF), “Ubinal M40” (made by 2-hydroxy-4-methoxybenzophenone BASF), “Pulsol SLX” (made by dimethicodiethylbenzalmalonate DSM), “Pulsol 340” (2-ethylhexyl 2-cyano-3,3-diphenylacrylate, manufactured by DSM), “Pulsol HMS” (homomothyl salicylate, manufactured by DSM), “Pulsol EMS” (made by octyl salicylate, DSM) can be exemplified. .
UV−B吸収剤の含有量は、皮膚外用剤全量に対して通常0.1質量%以上、好ましくは0.5質量%以上であり、また、通常10質量%以下、好ましくは7質量%以下である。上記範囲の含有量により、より良好に紫外線吸収効果を発揮できる。 The content of the UV-B absorber is usually 0.1% by mass or more, preferably 0.5% by mass or more, and usually 10% by mass or less, preferably 7% by mass or less, based on the total amount of the external preparation for skin. It is. With the content in the above range, the ultraviolet absorption effect can be exhibited better.
本実施態様に係る皮膚外用剤は、皮膚に外用で投与されるものであれば特段の限定はなく、例えば、医薬部外品を包含する化粧料、皮膚外用雑貨等が好適に例示できる。化粧料として用いられることがより好ましい。
本実施態様に係る皮膚外用剤は、通常知られている、乳液剤形、エッセンス剤形、クリーム剤形、粉体含有剤形の何れをも取ることが出来る。化粧料としては、基礎化粧料、毛髪化粧料、メークアップ化粧料などの何れもが適用可能であるが、紫外線吸収効果が良好であることから、サンスクリーンに適用することが特に好ましい。
The skin external preparation according to this embodiment is not particularly limited as long as it is externally administered to the skin, and examples thereof include cosmetics including quasi-drugs, and skin external goods. More preferably, it is used as a cosmetic.
The external preparation for skin according to this embodiment may take any of the conventionally known emulsion dosage forms, essence dosage forms, cream dosage forms, and powder-containing dosage forms. The cosmetics, basic cosmetics, hair cosmetics, but any such makeup cosmetics can be applied, since the ultraviolet absorption Osamuko result is good, it is particularly preferable to apply the sunscreen.
本実施態様に係る皮膚外用剤に於いては、前記の成分以外に、通常化粧料や皮膚外用医薬で使用される任意成分を含有することが出来る。この様な任意成分としては、例えば:マカデミアナッツ油、アボカド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;
流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;
オレイン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;
セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール類;
イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;
ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン、アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;
脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;
塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;
ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、アシルメチルタウリン等の両性界面活性剤類;
ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタ
ン等) 、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコー
ル脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキシエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等) 、POEアルキルエ
ーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;
ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキシレングリコール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;
ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;
グアガム、クインスシード、カラギーナン、ガラクタン、アラビアガム、ペクチン、マンナン、デンプン、キサンタンガム、カードラン、メチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、メチルヒドロキシプロピルセルロース、コンドロイチン硫酸、デルマタン硫酸、グリコーゲン、ヘパラン硫酸、ヒアルロン酸、ヒアルロン酸ナトリウム、トラガントガム、ケラタン硫酸、コンドロイチン、ムコイチン硫酸、ヒドロキシエチルグアガム、カルボキシメチルグアガム、デキストラン、ケラト硫酸、ローカストビーンガム、サクシノグルカン、カロニン酸,キチン、キトサン、カルボキシメチルキチン、寒天、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アルキル変性カルボキシビニルポリマー、ポリアクリル酸ナトリウム、ポリエチレングリコール、ベントナイト等の増粘剤;
表面を処理されていてもよい、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類;
表面を処理されていてもよい、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類;
表面を処理されていてもよい、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類;
レーキ化されていてもよい赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;
ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類;
パラアミノ安息香酸系紫外線吸収剤、アントラニル酸系紫外線吸収剤、サリチル酸系紫外線吸収剤、桂皮酸系紫外線吸収剤、ベンゾフェノン系紫外線吸収剤、糖系紫外線吸収剤、2−(2'−ヒドロキシ−5'−t−オクチルフェニル)ベンゾトリアゾール、4−メトキ
シ−4'−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;
エタノール、イソプロパノール等の低級アルコール類;
ビタミンA又はその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2又はその誘導体、ビタミンB12、ビタミンB15又はその誘導体等のビタミンB類、α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、
パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類;
などが好ましく例示できる。
In the external preparation for skin according to this embodiment, in addition to the above-described components, optional components that are usually used in cosmetics and external preparations for skin can be contained. Such optional ingredients include, for example: macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, palm oil, palm oil, liquid lanolin, hydrogenated coconut oil Oils such as hardened oil, mole, hardened castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, waxes;
Hydrocarbons such as liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum, microcrystalline wax;
Higher fatty acids such as oleic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid;
Higher alcohols such as cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol;
Cetyl isooctanoate, isopropyl myristate, hexyl decyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, diisostearyl malate, ethylene glycol di-2-ethylhexanoate, neopentyl glycol dicaprate, Synthetic esters such as glycerin di-2-heptylundecanoate, glyceryl tri-2-ethylhexanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, pentane erythritol tetra-2-ethylhexanoate Oils;
Linear polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane, amino-modified polysiloxane, polyether-modified poly Oil agents such as silicone oil such as siloxane, alkyl-modified polysiloxane, and modified polysiloxane such as fluorine-modified polysiloxane;
Anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, alkylsulfuric acid triethanolamine ether;
Cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride, laurylamine oxide;
Betaine surfactants (alkyl betaines, amide betaines, sulfobetaines, etc.), imidazoline amphoteric surfactants (such as 2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy disodium salt), acylmethyl taurine Amphoteric surfactants such as;
Sorbitan fatty acid esters (such as sorbitan monostearate and sorbitan sesquioleate), glycerin fatty acids (such as glyceryl monostearate), propylene glycol fatty acid esters (such as propylene glycol monostearate), hydrogenated castor oil derivatives, glycerin alkyl ether POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid esters (POE-glycerin monoisosteare) Rate), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyl) Decyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl ether, etc.), pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), tetronics, POE castor oil / cured castor Nonionic surfactants such as oil derivatives (POE castor oil, POE hydrogenated castor oil, etc.), sucrose fatty acid esters, alkyl glucosides;
Polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexylene glycol, 1 Polyhydric alcohols such as 1,2-hexanediol and 1,2-octanediol;
Moisturizing ingredients such as sodium pyrrolidonecarboxylate, lactic acid, sodium lactate;
Gua gum, quince seed, carrageenan, galactan, arabic gum, pectin, mannan, starch, xanthan gum, curdlan, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, methylhydroxypropylcellulose, chondroitin sulfate, dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, Sodium hyaluronate, gum tragacanth, keratan sulfate, chondroitin, mucoitin sulfate, hydroxyethyl guar gum, carboxymethyl guar gum, dextran, kerato sulfate, locust bean gum, succinoglucan, carolinic acid, chitin, chitosan, carboxymethyl chitin, agar, polyvinyl alcohol , Polyvinylpyrrolidone, carboxyvinyl polymer, alkyl-modified carboxyl Vinyl polymers, sodium polyacrylate, polyethylene glycol, bentonite thickener;
Powders such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, barium sulfate, etc. whose surface may be treated;
Inorganic pigments such as bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide, the surface of which may be treated;
Pearl agents such as titanium mica, fish phosphorus foil, bismuth oxychloride, etc. whose surface may be treated;
Red 202, Red 228, Red 226, Yellow 4, Blue 404, Yellow 5, Red 505, Red 230, Red 223, Orange 201, Red 213 which may be raked Organic dyes such as Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Red No. 204;
Organic powders such as polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer;
Paraaminobenzoic acid UV absorbers, anthranilic acid UV absorbers, salicylic acid UV absorbers, cinnamic acid UV absorbers, benzophenone UV absorbers, sugar UV absorbers, 2- (2'-hydroxy-5 ' UV absorbers such as -t-octylphenyl) benzotriazole, 4-methoxy-4'-t-butyldibenzoylmethane;
Lower alcohols such as ethanol and isopropanol;
Vitamin A or a derivative thereof, vitamin B 6 hydrochloride, vitamin B 6 tripalmitate, vitamin B 6 dioctanoate, vitamin B 2 or a derivative thereof, vitamin B 12 such as vitamin B 12 , vitamin B 15 or a derivative thereof, α-tocopherol , Β-tocopherol, γ-tocopherol, vitamin E such as vitamin E acetate, vitamin D, vitamin H,
Vitamins such as pantothenic acid, panthetin, pyrroloquinoline quinone;
Etc. can be preferably exemplified.
以下、実施例を用いて本発明をより詳細に説明するが、本発明が以下の実施例のみに限定されないことはいうまでもない。
<実施例1>シリコーン被覆微粒子二酸化チタンの製造例1
微粒子二酸化チタン(「タイペークTTO−M−2」 石原産業株式会社製)85g、反応性ポリオルガノシロキサンとしてα-トリエトキシポリメチルポリシロキサン(重合
度30、分子量分散度1.19、片末端基エトキシ基)8.0g及びフェニル基を有するシリコーン(「シリコーンKF54」 信越化学株式会社製)7.0gをイソプロピルア
ルコール50mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、本発明のシリコーン被覆微粒子二酸化チタ
ン1を得た。
EXAMPLES Hereinafter, although this invention is demonstrated in detail using an Example, it cannot be overemphasized that this invention is not limited only to a following example.
<Example 1> Production example 1 of silicone-coated fine particle titanium dioxide
85 g of fine particle titanium dioxide (“Taipeku TTO-M-2” manufactured by Ishihara Sangyo Co., Ltd.), α-triethoxypolymethylpolysiloxane as a reactive polyorganosiloxane (polymerization degree 30, molecular weight dispersity 1.19, single-terminal ethoxy group) Group) 8.0 g of a silicone having a phenyl group (“silicone KF54” manufactured by Shin-Etsu Chemical Co., Ltd.) 7.0 g dissolved in 50 ml of isopropyl alcohol was stirred and mixed in a Henschel mixer.
The mixture was heated for 8 hours treatment with 0.99 ° C., to obtain a silicone down the covering particles of titanium dioxide of the present invention.
<実施例2>シリコーン被覆微粒子二酸化チタンの製造例2
微粒子二酸化チタン(「MT−100T」 テイカ株式会社製)85g、反応性ポリオルガノシロキサンとしてα-モノヒドロキシポリシロキサン(重合度35、分子量分散度
1.21、片末端基がモノシラノール基)7.5g及びフェニル基を有するシリコーン(「シリコーンKF56」 信越化学株式会社製)7.5gをイソプロピルアルコール50
mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、本発明のシリコーン被覆微粒子二酸化チタ
ン2を得た。
<Example 2> Production example 2 of silicone-coated fine particle titanium dioxide
6. 85 g of fine particle titanium dioxide (“MT-100T” manufactured by Teica Co., Ltd.), α-monohydroxypolysiloxane as a reactive polyorganosiloxane (polymerization degree 35, molecular weight dispersity 1.21, one end group is a monosilanol group) 5 g of silicone having a phenyl group ("silicone KF56" manufactured by Shin-Etsu Chemical Co., Ltd.) 7.5 g of isopropyl alcohol 50
The solution dissolved in ml was stirred and mixed in a Henschel mixer.
The mixture was heated for 8 hours treatment with 0.99 ° C., to obtain a silicone down the covering particles of titanium dioxide 2 of the present invention.
<比較例1>シリコーン被覆微粒子二酸化チタンの製造例3
微粒子二酸化チタン(「タイペークTTO−M−2」 石原産業株式会社製)85g、反応性ポリオルガノシロキサンとしてα-トリエトキシポリメチルポリシロキサン(重合
度30、分子量分散度1.19、片末端基エトキシ基)15.0gをイソプロピルアルコール50mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、シリコーン被覆微粒子二酸化チタン3を得
た。
Comparative Example 1 Production Example 3 of Silicone-Coated Fine Particle Titanium Dioxide
85 g of fine particle titanium dioxide (“Taipeku TTO-M-2” manufactured by Ishihara Sangyo Co., Ltd.), α-triethoxypolymethylpolysiloxane as a reactive polyorganosiloxane (polymerization degree 30, molecular weight dispersity 1.19, single-terminal ethoxy group) Base) A solution in which 15.0 g was dissolved in 50 ml of isopropyl alcohol was stirred and mixed in a Henschel mixer.
The mixture was heated for 8 hours treatment with 0.99 ° C., to obtain a silicone down the covering fine particulate titanium dioxide 3.
<比較例2>シリコーン被覆微粒子二酸化チタンの製造例4
微粒子二酸化チタン(「タイペークTTO−M−2」 石原産業株式会社製)85g、フェニル基を有するシリコーン(「シリコーンKF54」 信越化学株式会社製)15.
0gをイソプロピルアルコール50mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、シリコーン被覆微粒子二酸化チタン4を得
た。
Comparative Example 2 Production Example 4 of Silicone-Coated Fine Particle Titanium Dioxide
15. Fine particle titanium dioxide (“Taipeke TTO-M-2” manufactured by Ishihara Sangyo Co., Ltd.) 85 g, phenyl group silicone (“Silicone KF54” manufactured by Shin-Etsu Chemical Co., Ltd.)
A solution prepared by dissolving 0 g in 50 ml of isopropyl alcohol was stirred and mixed in a Henschel mixer.
The mixture was heated for 8 hours treatment with 0.99 ° C., to obtain a silicone down the covering particles of titanium dioxide 4.
<実施例3>シリコーン被覆微粒子酸化亜鉛の製造例1
微粒子酸化亜鉛(「マックスライトZS−032」 昭和電工株式会社製)85g、反応性ポリオルガノシロキサンとしてα-トリエトキシポリメチルポリシロキサン(重合度
30、分子量分散度1.19、片末端基エトキシ基)8.0g及びフェニル基を有するシリコーン(「シリコーンKF54」 信越化学株式会社製)7.0gをイソプロピルアル
コール50mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、本発明のシリコーン被覆微粒子酸化亜鉛1
を得た。
<Example 3> Production example 1 of silicone- coated fine particle zinc oxide
85 g of fine particle zinc oxide (“Maxlite ZS-032”, Showa Denko KK), α-triethoxypolymethylpolysiloxane as a reactive polyorganosiloxane (polymerization degree 30, molecular weight dispersity 1.19, single-terminal ethoxy group) ) 8.0 g and a phenyl group-containing silicone (“silicone KF54” manufactured by Shin-Etsu Chemical Co., Ltd.) 7.0 g in 50 ml of isopropyl alcohol was stirred and mixed in a Henschel mixer.
The mixture was heated for 8 hours treatment with 0.99 ° C., silicone down the covering zinc oxide particles 1 of the present invention
Got.
<実施例4>シリコーン被覆微粒子酸化亜鉛の製造例2
微粒子酸化亜鉛(「FZO50」 石原産業株式会社製)85g、反応性ポリオルガノシロキサンとしてα-モノヒドロキシポリシロキサン(重合度35、分子量分散度1.2
1、片末端基がモノシラノール基)7.5g及びフェニル基を有するシリコーン(「シリコーンKF56」 信越化学株式会社製)7.5gをイソプロピルアルコール50mlに
溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、本発明のシリコーン被覆微粒子酸化亜鉛2
を得た。
<Example 4> Production example 2 of silicone- coated fine particle zinc oxide
85 g of fine particle zinc oxide (“FZO50” manufactured by Ishihara Sangyo Co., Ltd.), α-monohydroxypolysiloxane (polymerization degree 35, molecular weight dispersity 1.2) as reactive polyorganosiloxane
1. A solution prepared by dissolving 7.5 g of a silicone having a phenyl group (monosilanol group at one end group) and 7.5 g of “silicone KF56” manufactured by Shin-Etsu Chemical Co., Ltd. in 50 ml of isopropyl alcohol was stirred and mixed in a Henschel mixer. .
The mixture was heated for 8 hours treatment with 0.99 ° C., silicone down the covering zinc oxide particles 2 of the present invention
Got.
<比較例3>シリコーン被覆微粒子酸化亜鉛の製造例3
微粒子酸化亜鉛(「マックスライトZS−032」 昭和電工株式会社製)85g、反応性ポリオルガノシロキサンとしてα−トリエトキシポリメチルポリシロキサン(重合度30、分子量分散度1.19、片末端基エトキシ基)15.0gをイソプロピルアルコール50mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、シリコーン被覆微粒子酸化亜鉛3を得た。
Comparative Example 3 Production Example 3 of Silicone-Coated Fine Particle Zinc Oxide
85 g of fine particle zinc oxide (“Maxlite ZS-032” manufactured by Showa Denko KK), α-triethoxypolymethylpolysiloxane as a reactive polyorganosiloxane (polymerization degree 30, molecular weight dispersity 1.19, single-terminal ethoxy group) ) A solution of 15.0 g dissolved in 50 ml of isopropyl alcohol was stirred and mixed in a Henschel mixer.
The mixture was heated for 8 hours treatment with 0.99 ° C., to obtain a silicone down the covering zinc oxide particles 3.
<比較例4>シリコーン被覆微粒子酸化亜鉛の製造例4
微粒子酸化亜鉛(「マックスライトZS−032」 昭和電工株式会社製)85g、フェニル基を有するシリコーン(「シリコーンKF54」 信越化学株式会社製)15.0
gをイソプロピルアルコール50mlに溶解させた溶液をヘンシェルミキサー中で攪拌混合した。
この混合物を150℃で8時間加熱処理し、シリコーン被覆微粒子酸化亜鉛4を得た。
Comparative Example 4 Production Example 4 of Silicone-Coated Fine Particle Zinc Oxide
85 g of fine particle zinc oxide (“Maxlite ZS-032” manufactured by Showa Denko KK), phenyl-containing silicone (“Silicone KF54” manufactured by Shin-Etsu Chemical Co., Ltd.) 15.0
A solution prepared by dissolving g in 50 ml of isopropyl alcohol was stirred and mixed in a Henschel mixer.
This mixture was heat-treated at 150 ° C. for 8 hours to obtain silicone-coated fine particle zinc oxide 4.
<試験例1>シリコーン被覆微粒子二酸化チタン、酸化亜鉛の分散安定性
トリ−2エチルヘキサン酸グリセリルとジメチコン(20cs)を質量比7:3で混合した混合油剤26.85g、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル0.15g及び上記で調製したシリコーン被覆微粒子二酸化チタン1〜4及びシリコーン被覆微粒子酸化亜鉛1〜4を、それぞれ3.0gを50mlガラス製スクリュー瓶にとり10分間超音波処理を行い均一分散させた。この分散系を24時間放置し、シリコーン被覆微粒子二酸化チタン及び酸化亜鉛の分散状態を肉眼にて観察した。結果を表1に示す。
<Test Example 1> Dispersion stability of silicone-coated fine particle titanium dioxide and zinc oxide 26.85 g of a mixed oil prepared by mixing glyceryl tri-2-ethylhexanoate and dimethicone (20 cs) at a mass ratio of 7: 3, hexyl diethylaminohydroxybenzoyl benzoate 0.15 g and 3.0 g of the silicone-coated fine particle titanium dioxide 1 to 4 and the silicone-coated fine particle zinc oxide 1 to 4 prepared above were each placed in a 50 ml glass screw bottle and subjected to ultrasonic treatment for 10 minutes to be uniformly dispersed. This dispersion was allowed to stand for 24 hours, and the dispersion state of the silicone-coated fine particle titanium dioxide and zinc oxide was observed with the naked eye. The results are shown in Table 1.
表1から明らかなように本発明のシリコーン被覆微粒子金属酸化物は、UV吸収剤を含有する油剤中で、優れた分散安定性を有する。 As is apparent from Table 1, the silicone-coated fine particle metal oxide of the present invention has excellent dispersion stability in an oil containing a UV absorber.
<製造例1>シリコーン被覆微粒子二酸化チタンペースト1の調製
50gの実施例1のシリコーン被覆微粒子二酸化チタン1、デカメチルシクロペンタシロキサン46g、セスキイソステアリン酸ソルビタン4gをコボールミル(神鋼パンテック株式会社製)にとり、4時間混合粉砕を行い、シリコーン被覆微粒子二酸化チタンペースト1を得た。
<Production example 1> Preparation of silicone-coated fine particle titanium dioxide paste 1 50 g of silicone-coated fine particle titanium dioxide 1 of Example 1, 46 g of decamethylcyclopentasiloxane, and 4 g of sorbitan sesquiisostearate were placed in a coball mill (manufactured by Shinko Pantech Co., Ltd.). The mixture was pulverized for 4 hours to obtain a silicone-coated fine particle titanium dioxide paste 1.
<製造例2>シリコーン被覆微粒子酸化亜鉛ペースト1の調製
50gの実施例3のシリコーン被覆微粒子酸化亜鉛1、デカメチルシクロペンタシロキサン46g、セスキイソステアリン酸ソルビタン4gをコボールミル(神鋼パンテック株式会社製)にとり、4時間混合粉砕を行い、シリコーン被覆微粒子酸化亜鉛ペースト1を得た。
<Production Example 2> Preparation of Silicone-Coated Fine Particle Zinc Oxide Paste 50 g of silicone-coated fine particle zinc oxide 1 of Example 3, 46 g of decamethylcyclopentasiloxane, and 4 g of sorbitan sesquiisostearate were taken in a coball mill (made by Shinko Pantech Co., Ltd.). The mixture was pulverized for 4 hours to obtain a silicone-coated fine particle zinc oxide paste 1.
<実施例5〜8、比較例5〜6>
表2に示す処方に従って、本発明の乳化形化粧料である、油中水形のサンスクリーン化粧料及び比較例の油中水形のサンスクリーン化粧料を調製した。すなわち、成分(イ)を75℃に加熱し、攪拌混合した。次に、成分(イ)に成分(ロ)を添加し、加熱を続けながら、ディスパーを用いて5000rpmで4分間攪拌し、成分(イ)に成分(ロ)を均一に分散させた。さらに、成分(ハ)を75℃に加熱、攪拌混合し、75℃を保ちながら、成分(イ)と成分(ロ)の混合物に成分(ハ)を攪拌下、添加し乳化を行った。その後、室温まで冷却し、油中水形のサンスクリーン化粧料を得た。なお表2中の数字は質量%を表す。
<Examples 5-8, Comparative Examples 5-6>
According to the formulation shown in Table 2, a water-in-oil sunscreen cosmetic and a comparative water-in-oil sunscreen cosmetic, which are emulsified cosmetics of the present invention, were prepared. That is, component (a) was heated to 75 ° C. and mixed with stirring. Next, the component (b) was added to the component (a), and the mixture was stirred for 4 minutes at 5000 rpm using a disper while continuing the heating, so that the component (b) was uniformly dispersed in the component (a). Furthermore, the component (c) was heated to 75 ° C. and mixed with stirring, and while maintaining the temperature at 75 ° C., the component (c) was added to the mixture of the component (a) and the component (b) with stirring to perform emulsification. Thereafter, it was cooled to room temperature to obtain a water-in-oil sunscreen cosmetic. The numbers in Table 2 represent mass%.
<試験例2>SPF値の測定
ISO24444の方法により実施例5〜8、比較例5〜6のサンスクリーン化粧料を塗布した場合のSPF値を測定した。結果を表3に示す。
<Test Example 2> Measurement of SPF Value The SPF value was measured when the sunscreen cosmetics of Examples 5 to 8 and Comparative Examples 5 to 6 were applied by the method of ISO 24444. The results are shown in Table 3.
<試験例3>UVAPF値の評価
ISO24442の試験方法により実施例5〜8、比較例5〜6のサンスクリーン化粧料を塗布した場合のUVAPF値を評価した。結果を表3に示す。
<Test Example 3> Evaluation of UVAPF Value The UVAPF value was evaluated when the sunscreen cosmetics of Examples 5 to 8 and Comparative Examples 5 to 6 were applied according to the test method of ISO24442. The results are shown in Table 3.
<試験例4>保存安定性の評価
実施例5〜8、比較例5〜6のサンスクリーン化粧料を50℃で3ヶ月保存した後、試験例1及び2の方法でSPF値及びUVAPF値を測定した。保存後の測定値の保存前の
塗布直後の測定値対する割合、すなわち、維持率を算出した。維持率が100%に近いほど、保存により紫外線防御効果が低下していないことを意味する。結果を表3に示す。
Test Example 4 Storage Stability Evaluation After the sunscreen cosmetics of Examples 5 to 8 and Comparative Examples 5 to 6 were stored at 50 ° C. for 3 months, the SPF value and UVAPF value were determined by the methods of Test Examples 1 and 2. It was measured. The ratio of the measured value after storage to the measured value immediately after application before storage, that is, the maintenance ratio was calculated. The closer the maintenance rate is to 100%, the less the ultraviolet protective effect is reduced by storage. The results are shown in Table 3.
<試験例5>肌上での使用感の評価
熟練評価者5名により実施例5〜8、比較例5〜6のサンスクリーン化粧料を塗布した場合の使用感についての官能評価を行った。さっぱり感を以下の評価基準に基づき評価した。評価では、5名の平均値を求めそのサンスクリーン化粧料の評点とした。また、50℃で3ヶ月保存した後にも同様の評価を行った。結果を表3に示す。
さっぱり感が調製直後の比較例5と比較して:
かなりある 5点
ややある 4点
同等 3点
ややない 2点
かなりない 1点
<Test Example 5> Evaluation of feeling on the skin Sensory evaluation was performed on the feeling when the sunscreen cosmetics of Examples 5 to 8 and Comparative Examples 5 to 6 were applied by five skilled evaluators. The refreshing feeling was evaluated based on the following evaluation criteria. In the evaluation, the average value of 5 persons was obtained and used as the score of the sunscreen cosmetic. The same evaluation was performed after storage at 50 ° C. for 3 months. The results are shown in Table 3.
Compared with Comparative Example 5 immediately after preparation, the refreshing feeling:
There are quite 5 points Somewhat 4 points Equivalent 3 points Somewhat not 2 Points Not quite 1 point
表3から明らかなように本発明の皮膚外用剤は使用時のさっぱり感に優れ、A領域及びB領域の紫外線に対する防御効果が高い。また、これらの優れた機能は長期間の過酷な保存を経ても維持されている。 As is apparent from Table 3, the external preparation for skin of the present invention is excellent in a refreshing feeling during use and has a high protective effect against ultraviolet rays in the A region and the B region. Moreover, these excellent functions are maintained even after a long period of severe storage.
<実施例9〜12、比較例7〜8>
表4に示す処方に従って、本発明の乳化形化粧料である、水中油形のサンスクリーン化粧料及び比較例の水中油形のサンスクリーン化粧料を調製した。すなわち、成分(イ)を75℃に加熱し、攪拌混合した。次に、成分(イ)に成分(ロ)を添加し、加熱を続けながら、ディスパーを用いて5000rpmで4分間攪拌し、成分(イ)に成分(ロ)を均一に分散させた。さらに、成分(ハ)を75℃に加熱、攪拌混合し、75℃を保ちながら、成分(イ)と成分(ロ)の混合物に成分(ハ)を攪拌下、添加し乳化を行った。その後、室温まで冷却し、水中油形のサンスクリーン化粧料を得た。なお表4中の数字は質量%を表す。また、実施例9〜12及び比較例7〜8のサンスクリーン化粧料について、試験例2〜4と同様に、塗布直後のSPF値及びUVAPF値の測定、保存後のSPF値及びPFA値の測定を行い、SPF値及びUVAPF値の維持率を算出した。また、試験例5と同様に、使用時のさっぱり感を評価した。結果を表5に示す。
<Examples 9-12, Comparative Examples 7-8>
According to the formulation shown in Table 4, an oil-in-water sunscreen cosmetic and a comparative oil-in-water sunscreen cosmetic, which are emulsified cosmetics of the present invention, were prepared. That is, component (a) was heated to 75 ° C. and mixed with stirring. Next, the component (b) was added to the component (a), and the mixture was stirred for 4 minutes at 5000 rpm using a disper while continuing the heating, so that the component (b) was uniformly dispersed in the component (a). Furthermore, the component (c) was heated to 75 ° C. and mixed with stirring, and while maintaining the temperature at 75 ° C., the component (c) was added to the mixture of the component (a) and the component (b) with stirring to perform emulsification. Thereafter, the mixture was cooled to room temperature to obtain an oil-in-water sunscreen cosmetic. The numbers in Table 4 represent mass%. Moreover, about the sunscreen cosmetics of Examples 9-12 and Comparative Examples 7-8, similarly to Test Examples 2-4, measurement of SPF value and UVAPF value immediately after application, measurement of SPF value and PFA value after storage The maintenance rate of SPF value and UVAPF value was calculated. Moreover, the refreshing feeling at the time of use was evaluated similarly to Test Example 5. The results are shown in Table 5.
表5の結果から明らかなように本発明の皮膚外用剤は使用時のさっぱり感に優れ、A領域及びB領域の紫外線に対する防御効果が高く、これらの優れた機能は長期間の過酷な保存を経ても維持されていることが水中油剤形においても確認された。 As is apparent from the results in Table 5, the external preparation for skin of the present invention has a refreshing feeling when used, and has a high protective effect against ultraviolet rays in the A region and B region. It was also confirmed in the oil-in-water dosage form that it was maintained even after passing.
本発明は日焼け止め化粧料等に活用できる。 The present invention can be used for sunscreen cosmetics and the like.
Claims (7)
(a)重合度が25以上100以下、重量平均分子量Mwと数平均分子量Mnとの比Mw/Mnの値が1以上1.3以下であって、少なくとも一方の分子鎖末端にアルコキシ基、水酸基、ハロゲン原子、アミノ基及びイミノ基からなる群から選択される少なくとも1種を有する直鎖状の反応性オルガノポリシロキサン
(b)少なくとも1つのフェニル基を有するオルガノポリシロキサン A skin external preparation containing a particulate metal oxide coated with the following (a) and (b) and an ultraviolet absorber.
(A) The degree of polymerization is 25 or more and 100 or less, and the ratio Mw / Mn of the weight average molecular weight Mw and the number average molecular weight Mn is 1 or more and 1.3 or less. , halogen atom, organopolysiloxane down with a linear reactive organopolysiloxane emissions (b) at least one phenyl group having at least one selected from the group consisting of amino groups and imino groups
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013178816A JP6366241B2 (en) | 2013-08-30 | 2013-08-30 | Fine particle metal oxide and external preparation for skin containing the fine particle metal oxide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013178816A JP6366241B2 (en) | 2013-08-30 | 2013-08-30 | Fine particle metal oxide and external preparation for skin containing the fine particle metal oxide |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015048309A JP2015048309A (en) | 2015-03-16 |
JP2015048309A5 JP2015048309A5 (en) | 2016-09-23 |
JP6366241B2 true JP6366241B2 (en) | 2018-08-01 |
Family
ID=52698608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013178816A Active JP6366241B2 (en) | 2013-08-30 | 2013-08-30 | Fine particle metal oxide and external preparation for skin containing the fine particle metal oxide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6366241B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210090459A (en) | 2020-01-10 | 2021-07-20 | 주식회사 엘지에너지솔루션 | Pressurized jig for removing gas traps and a method of manufacturing a secondary battery using the same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3567335B2 (en) * | 1993-12-28 | 2004-09-22 | 三好化成株式会社 | Organosilicon compound-treated pigment or extender, method for producing the same and cosmetics |
JP3822782B2 (en) * | 2000-07-06 | 2006-09-20 | 三好化成株式会社 | Sebum-adsorbing powder and use thereof |
JP2003212711A (en) * | 2002-01-24 | 2003-07-30 | Shiseido Co Ltd | Make-up cosmetic |
JP2004315467A (en) * | 2003-04-18 | 2004-11-11 | Miyoshi Kasei Inc | Sebum adsorbing powder and use thereof |
-
2013
- 2013-08-30 JP JP2013178816A patent/JP6366241B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015048309A (en) | 2015-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4560122B2 (en) | Titanium oxide dispersion and cosmetics containing the same | |
JP6014184B2 (en) | Emulsified cosmetics | |
JP5808083B2 (en) | Sunscreen cosmetics | |
EP2915524A1 (en) | Sunscreen cosmetic | |
JPWO2017057676A1 (en) | Sunscreen cosmetics | |
TW202224666A (en) | Water-in-oil emulsion cosmetic | |
JP4915729B2 (en) | O / W emulsified cosmetic | |
JP2017071580A (en) | Oil-in-water type emulsion composition | |
US8420066B2 (en) | O/W emulsion cosmetic composition | |
JP6029822B2 (en) | Oil-in-water emulsion composition | |
JP6674816B2 (en) | Water-in-oil emulsion composition | |
JP2013112615A (en) | Emulsion type cosmetic | |
JP6366241B2 (en) | Fine particle metal oxide and external preparation for skin containing the fine particle metal oxide | |
JP6383141B2 (en) | Surface-treated powder and skin external preparation containing the surface-treated powder | |
JP2018168134A (en) | Oil-in-water type cosmetic | |
JP5892739B2 (en) | UV protection cosmetics | |
JP2015048305A (en) | Surface treated powder and external preparation for skin containing surface treated powder | |
JP2015048304A (en) | Particulate metal oxide, and external preparation for skin containing particulate metal oxide | |
JP2015030723A (en) | Emulsifier type sunscreen cosmetic | |
JP2015048311A (en) | Emulsified cosmetic | |
JP6038433B2 (en) | Emulsified cosmetic | |
JP2015048312A (en) | Emulsified cosmetic | |
JP2015048313A (en) | Emulsified cosmetic | |
JP5878783B2 (en) | Emulsified cosmetic | |
JP2015048314A (en) | Emulsified cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160802 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160802 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170517 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170627 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20180130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180501 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20180510 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180619 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180703 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6366241 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |